Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02608684
Brief Title: A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer (PemCiGem)

First Submitted : November 12, 2015
First Submitted that Met QC Criteria : November 17, 2015
First Posted : November 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 11, 2019
Last Update Posted : April 12, 2019